Table 1:
male WT | female WT | ||||
---|---|---|---|---|---|
disorder | Numbera | p valueb | disorder | numbera | p valueb |
cancer | 202 | 8.41E-09 | metabolism | 28 | 1.24E-06 |
connective tissue | 67 | 1.70E-06 | gastrointestinal | 21 | 1.99E-06 |
development | 54 | 3.57E-06 | cancer | 85 | 2.36E-06 |
endocrine system | 40 | 3.69E-05 | genetic | 34 | 7.50E-05 |
metabolism | 38 | 4.61E-05 | development | 21 | 9.62E-05 |
male KO | female KO | ||||
disorder | numbera | p valueb | disorder | numbera | p valueb |
cancer | 123 | 1.77E-09 | immulogical | 91 | 2.34E-22 |
reproductive system | 57 | 2.51E-09 | connective tissue | 64 | 4.85E-20 |
connective tissue | 36 | 2.92E-08 | inflammatory | 87 | 4.85E-20 |
inflammatory | 55 | 2.92E-08 | skeletal and muscular | 68 | 4.85E-20 |
skeletal and muscular | 40 | 2.92E-08 | metabolic | 49 | 4.85E-20 |
number for genes involved in disorders with at least 2 fold change in mRNA levels.
statistics significance in comparisons between 24 and 6-month-old mice.